Cost and Success Rates of Three Lower Extremity Reconstructive Modalities

Watch On Demand

In this webinar, Dr. John Fischer, Assistant Professor of Surgery and Director of Clinical Research at the University of Pennsylvania Health System, presents data from “Comparative Effectiveness Analysis of Complex Lower Extremity Reconstruction: Outcomes and Costs for Biologically Based, Local Tissue Rearrangement, and Free Flap Reconstruction.”

This study, published in Plastic and Reconstructive Surgery, compares the effectiveness and cost of three modalities commonly used for complex lower extremity reconstruction: Integra® Bilayer Wound Matrix, local tissue rearrangement and free flap.

The study was a retrospective, 3-arm comparative study over seven years with 501 subjects.

Watch the 12-minute video to hear Dr. Fischer discuss findings such as:

    • Which modality resulted in an increase in overall total cost of care
    • Which treatment options showed lowest cost, median procedure length and overall length of stay in certain patient populations
    • The relationship between patient characteristics and probability of success with dermal matrices and other reconstructive modalities

“These findings are important because it gives us a glimpse of how to potentially optimally use Integra [Bilayer Wound Matrix] as part of a comprehensive reconstructive paradigm to address lower extremity defects,” says Dr. Fischer.

Reference:

Kozak GM, Hsu JY, Broach RB, Shakir S, Calvert C, Stranix JT, Messa C 4th, Levin LS, Serletti JM, Kovach SJ, Fischer JP. Comparative Effectiveness Analysis of Complex Lower Extremity Reconstruction: Outcomes and Costs for Biologically Based, Local Tissue Rearrangement, and Free Flap Reconstruction. Plast Reconstr Surg. 2020 Mar;145(3):608e-616e.

INDICATIONS: Integra® Bilayer Wound Matrix is indicated for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds. The device is intended for one-time use.

CONTRAINDICATIONS: This device should not be used in patients with known sensitivity to bovine collagen or chondroitin materials. This device is not indicated for use in third-degree burns.

PRECAUTIONS:

  • Do not resterilize. Discard all opened and unused portions of Integra Bilayer Wound Matrix.
  • Device is sterile if the package is unopened and undamaged. Do not use if the package seal is broken.
  • Discard device if mishandling has caused possible damage or contamination.
  • Integra Bilayer Matrix Wound Dressing should not be applied until excessive exudate, bleeding, acute swelling and infection are controlled.
  • Debridement or excision must be done thoroughly to remove any remaining necrotic tissue that may cause infection.
  • The following complications are possible with the use of wound dressings. If any of the conditions occur, the device should be removed: infection, chronic inflammation (initial application of wound dressings may be associated with transient, mild, localized inflammation), allergic reaction, excessive redness, pain or swelling.

Please fill out the below form to access this premium content:


    By submitting this form, you agree to our Privacy Policy and Terms of Use.

    Cost and Success Rates of Three Lower Extremity Reconstructive Modalities

    Watch On Demand

    In this webinar, Dr. John Fischer, Assistant Professor of Surgery and Director of Clinical Research at the University of Pennsylvania Health System, presents data from “Comparative Effectiveness Analysis of Complex Lower Extremity Reconstruction: Outcomes and Costs for Biologically Based, Local Tissue Rearrangement, and Free Flap Reconstruction.”

    This study, published in Plastic and Reconstructive Surgery, compares the effectiveness and cost of three modalities commonly used for complex lower extremity reconstruction: Integra® Bilayer Wound Matrix, local tissue rearrangement and free flap.

    The study was a retrospective, 3-arm comparative study over seven years with 501 subjects.

    Watch the 12-minute video to hear Dr. Fischer discuss findings such as:

      • Which modality resulted in an increase in overall total cost of care
      • Which treatment options showed lowest cost, median procedure length and overall length of stay in certain patient populations
      • The relationship between patient characteristics and probability of success with dermal matrices and other reconstructive modalities

    “These findings are important because it gives us a glimpse of how to potentially optimally use Integra [Bilayer Wound Matrix] as part of a comprehensive reconstructive paradigm to address lower extremity defects,” says Dr. Fischer.

    Reference:

    Kozak GM, Hsu JY, Broach RB, Shakir S, Calvert C, Stranix JT, Messa C 4th, Levin LS, Serletti JM, Kovach SJ, Fischer JP. Comparative Effectiveness Analysis of Complex Lower Extremity Reconstruction: Outcomes and Costs for Biologically Based, Local Tissue Rearrangement, and Free Flap Reconstruction. Plast Reconstr Surg. 2020 Mar;145(3):608e-616e.

    Please fill out the below form to access this premium content:


      By submitting this form, you agree to our Privacy Policy and Terms of Use.

      INDICATIONS: Integra® Bilayer Wound Matrix is indicated for the management of wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds. The device is intended for one-time use.

      CONTRAINDICATIONS: This device should not be used in patients with known sensitivity to bovine collagen or chondroitin materials. This device is not indicated for use in third-degree burns.

      PRECAUTIONS:

      • Do not resterilize. Discard all opened and unused portions of Integra Bilayer Wound Matrix.
      • Device is sterile if the package is unopened and undamaged. Do not use if the package seal is broken.
      • Discard device if mishandling has caused possible damage or contamination.
      • Integra Bilayer Matrix Wound Dressing should not be applied until excessive exudate, bleeding, acute swelling and infection are controlled.
      • Debridement or excision must be done thoroughly to remove any remaining necrotic tissue that may cause infection.
      • The following complications are possible with the use of wound dressings. If any of the conditions occur, the device should be removed: infection, chronic inflammation (initial application of wound dressings may be associated with transient, mild, localized inflammation), allergic reaction, excessive redness, pain or swelling.
      Share via
      Copy link
      Powered by Social Snap